United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 894,800 | 908,500 | 942,200 | 832,300 | 738,700 |
| Marketable Securities | 1,035,900 | 1,091,900 | 1,025,300 | 899,000 | 1,096,300 |
| Receivables | 198,700 | 212,800 | 173,400 | 141,100 | 157,400 |
| Inventories | 93,800 | 96,700 | 89,900 | 92,200 | 86,500 |
| Other current assets | 100,400 | 76,000 | 87,100 | 49,700 | 88,300 |
| TOTAL | $2,323,600 | $2,385,900 | $2,317,900 | $2,014,300 | $2,167,200 |
| Non-Current Assets | |||||
| PPE Net | 780,900 | 726,700 | 715,700 | 713,700 | 731,600 |
| Investments And Advances | 1,649,900 | 1,508,700 | 1,325,400 | 1,433,500 | 1,149,600 |
| Other Non-Current Assets | 414,700 | 427,600 | 485,900 | 479,500 | 566,600 |
| TOTAL | $2,845,500 | $2,663,000 | $2,527,000 | $2,626,700 | $2,447,800 |
| Total Assets | $5,169,100 | $5,048,900 | $4,844,900 | $4,641,000 | $4,615,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 174,600 | 210,500 | 189,800 | 165,000 | 187,000 |
| Other current liabilities | 130,800 | 109,500 | 121,600 | 137,400 | 136,300 |
| TOTAL | $305,400 | $320,000 | $311,400 | $302,400 | $323,300 |
| Non-Current Liabilities | |||||
| Long Term Debt | 800,000 | 800,000 | 800,000 | 800,000 | 800,000 |
| Other Non-Current Liabilities | 104,800 | 99,200 | 94,000 | 93,200 | 96,500 |
| TOTAL | $904,800 | $899,200 | $894,000 | $893,200 | $896,500 |
| Total Liabilities | $1,210,200 | $1,219,200 | $1,205,400 | $1,195,600 | $1,219,800 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45,132 | 45,037 | 44,892 | 44,796 | 44,544 |
| Common Shares | 700 | 700 | 700 | 700 | 700 |
| Retained earnings | 4,315,000 | 4,202,800 | 4,040,100 | 3,867,500 | 3,839,200 |
| Other shareholders' equity | -23,200 | -20,300 | -18,800 | -17,000 | -14,400 |
| TOTAL | $3,958,900 | $3,829,700 | $3,639,500 | $3,445,400 | $3,395,200 |
| Total Liabilities And Equity | $5,169,100 | $5,048,900 | $4,844,900 | $4,641,000 | $4,615,000 |